Dianna Koontz

999 total citations
21 papers, 718 citations indexed

About

Dianna Koontz is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Dianna Koontz has authored 21 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 18 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Dianna Koontz's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (11 papers). Dianna Koontz is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (11 papers). Dianna Koontz collaborates with scholars based in United States, Belgium and Spain. Dianna Koontz's co-authors include John W. Mellors, Urvi M. Parikh, Lee T. Bacheler, Elizabeth Fyne, Nicolas Sluis‐Cremer, Raymond F. Schinazi, Anthony R. Cillo, Jessica H. Brehm, Feiyu Hong and Mary F. Kearney and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Dianna Koontz

21 papers receiving 713 citations

Peers

Countries citing papers authored by Dianna Koontz

Since Specialization

Citations

This map shows the geographic impact of Dianna Koontz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianna Koontz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianna Koontz more than expected).

Fields of papers citing papers by Dianna Koontz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianna Koontz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianna Koontz. The network helps show where Dianna Koontz may publish in the future.

Co-authorship network of co-authors of Dianna Koontz

This figure shows the co-authorship network connecting the top 25 collaborators of Dianna Koontz. A scholar is included among the top collaborators of Dianna Koontz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianna Koontz. Dianna Koontz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy 2020 ·Journal of Clinical Microbiology ·Jana L. Jacobs, (unknown), Dianna Koontz, (unknown), Andrew Worlock, Karen Harrington, Sonia Bakkour, Mars Stone, Kathleen A. Shutt, Michael P. Busch, John W. Mellors	10
2	Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance 2019 ·Journal of Clinical Investigation ·Serena Spudich, Kevin R. Robertson, Ronald J. Bosch, Rajesh T. Gandhi, Joshua C. Cyktor, Hanna Mar, Bernard Macatangay, Christina M. Lalama, Charles R. Rinaldo, Ann C. Collier, Catherine Godfrey, Joseph J. Eron, Deborah K. McMahon, Jana L. Jacobs, Dianna Koontz, Evelyn Hogg, (unknown), John W. Mellors	82
3	Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy 2018 ·Virology ·Feiyu Hong, Jana L. Jacobs, Evgenia Aga, Anthony R. Cillo, Elizabeth Fyne, Dianna Koontz, Lu Zheng, John W. Mellors	15
4	Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay 2018 ·Journal of Clinical Virology ·Nicolas Margot, Dianna Koontz, Scott McCallister, John W. Mellors, Christian Callebaut	11
5	Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells 2017 ·PLoS Pathogens ·John Bui, Elias K. Halvas, Elizabeth Fyne, Michele D. Sobolewski, Dianna Koontz, Wei Shao, Brian T. Luke, Feiyu Hong, Mary F. Kearney, John W. Mellors	36
6	Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA 2016 ·Journal of Clinical Microbiology ·Feiyu Hong, Evgenia Aga, Anthony R. Cillo, (unknown), Guillaume Besson, Elizabeth Fyne, Dianna Koontz, Cheryl Jennings, Lu Zheng, John W. Mellors	83
7	A subset of infectious proviruses persist and expand following activation ex vivo 2015 ·Journal of Virus Eradication ·John Bui, Elias K. Halvas, Elizabeth Fyne, Michele D. Sobolewski, Dianna Koontz, Mary F. Kearney, Wei Shao, Feiyu Hong, John W. Mellors	1
8	Improved Single-Copy Assays for Quantification of Persistent HIV-1 Viremia in Patients on Suppressive Antiretroviral Therapy 2014 ·Journal of Clinical Microbiology ·Anthony R. Cillo, (unknown), Margaret A Bedison, Elizabeth M. Anderson, Mary F. Kearney, Elizabeth Fyne, Dianna Koontz, John M. Coffin, Michael Piatak, John W. Mellors	79
9	Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation 2013 ·Lara D. Veeken ·(unknown), Carmine V. Oddis, Danielle Goudeau, Noreen Fertig, (unknown), Chad E. Stephens, (unknown), Dianna Koontz, Marc C. Levesque	15
10	Zidovudine (AZT) Monotherapy Selects for the A360V Mutation in the Connection Domain of HIV-1 Reverse Transcriptase 2012 ·PLoS ONE ·Jessica H. Brehm, (unknown), Dianna Koontz, (unknown), Scott Hammer, David Katzenstein, John W. Mellors, Nicolas Sluis‐Cremer	7
11	Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors 2012 ·Clinical Infectious Diseases ·Jessica H. Brehm, Dianna Koontz, Carole L. Wallis, Kathleen A. Shutt, Ian Sanne, Robin Wood, James McIntyre, Wendy Stevens, Nicolas Sluis‐Cremer, John W. Mellors, (unknown)	33
12	The Base Component of 3′-Azido-2′,3′-Dideoxynucleosides Influences Resistance Mutations Selected in HIV-1 Reverse Transcriptase 2011 ·Antimicrobial Agents and Chemotherapy ·(unknown), Dianna Koontz, Ghazia Asif, Hongwang Zhang, Mervi Detorio, Sarah Solomon, Steven J. Coats, Nicolas Sluis‐Cremer, Raymond F. Schinazi, John W. Mellors	2
13	Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir 2009 ·Antiviral Therapy ·(unknown), Dianna Koontz, Holly Bazmi, (unknown), Joseph G. Jemsek, John W. Mellors	6
14	Anti-Human Immunodeficiency Virus Activity, Cross-Resistance, Cytotoxicity, and Intracellular Pharmacology of the 3′-Azido-2′,3′-Dideoxypurine Nucleosides 2009 ·Antimicrobial Agents and Chemotherapy ·Nicolas Sluis‐Cremer, Dianna Koontz, Leda Bassit, Brenda I. Hernández-Santiago, Mervi Detorio, (unknown), Franck Amblard, (unknown), (unknown), Steven J. Coats, Raymond F. Schinazi, John W. Mellors	13
15	Selection of Mutations in the Connection and RNase H Domains of Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Increase Resistance to 3′-Azido-3′-Dideoxythymidine 2007 ·Journal of Virology ·Jessica H. Brehm, Dianna Koontz, (unknown), Vinay K. Pathak, Nicolas Sluis‐Cremer, John W. Mellors	72
16	The K65R Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Exhibits Bidirectional Phenotypic Antagonism with Thymidine Analog Mutations 2006 ·Journal of Virology ·Urvi M. Parikh, Lee T. Bacheler, Dianna Koontz, John W. Mellors	104
17	The 3′-Azido Group Is Not the Primary Determinant of 3′-Azido-3′-deoxythymidine (AZT) Responsible for the Excision Phenotype of AZT-resistant HIV-1 2005 ·Journal of Biological Chemistry ·Nicolas Sluis‐Cremer, Dominique Arion, Urvi M. Parikh, Dianna Koontz, Raymond F. Schinazi, John W. Mellors, Michael A. Parniak	34
18	In Vitro Selection and Analysis of Human Immunodeficiency Virus Type 1 Resistant to Derivatives of β-2′,3′-Didehydro-2′,3′-Dideoxy-5-Fluorocytidine 2005 ·Antimicrobial Agents and Chemotherapy ·Jennifer Hammond, Urvi M. Parikh, Dianna Koontz, (unknown), Chung K. Chu, (unknown), Raymond F. Schinazi, John W. Mellors	14
19	In Vitro Activity of Structurally Diverse Nucleoside Analogs against Human Immunodeficiency Virus Type 1 with the K65R Mutation in Reverse Transcriptase 2005 ·Antimicrobial Agents and Chemotherapy ·Urvi M. Parikh, Dianna Koontz, Chung K. Chu, Raymond F. Schinazi, John W. Mellors	51
20	Alkylglycerol Prodrugs of Phosphonoformate Are Potent In Vitro Inhibitors of Nucleoside-Resistant Human Immunodeficiency Virus Type 1 and Select for Resistance Mutations That Suppress Zidovudine Resistance 2001 ·Antimicrobial Agents and Chemotherapy ·Jennifer Hammond, Dianna Koontz, Holly Bazmi, James R. Beadle, (unknown), Ganesh D. Kini, Kathy A. Aldern, Douglas D. Richman, Karl Y. Hostetler, John W. Mellors	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact